With glyphosate back up for re-registration in the EU in the year after next, it might be expected that those global anti-forces who oppose it will become vocal again.

Many, especially farmers, will be very aware of the ongoing cancer-causing controversy around the active and the huge pay-outs that are ongoing from new owners, Bayer, in the US. But is there a twist appearing in the story?